Abstract: The disclosure discloses a subpixel arrangement structure, a control method and a control system of a display panel, belongs to the technical field of control of display panels, and solves the problems of single subpixel arrangement mode and difficulty in color matching of an arrangement mode in the prior art. A display panel in the multiplexing structure is of an array structure composed of multiple light-emitting components, a distance between two adjacent light-emitting components in a same row is one basic unit, the light-emitting components in adjacent rows and a same column are staggered by a half basic unit, and the adjacent light-emitting components in any direction are light-emitting components with different primary colors. Three adjacent light-emitting components with three primary colors form a pixel unit, and a condition that multiple pixel units multiplex a same light-emitting component exists.

Abstract: The present disclosure provides a management method and a management system of a secondary battery, the secondary battery comprises N battery cells connected in series, N being a positive integer greater than or equal to 2. The management method comprises: acquiring a voltage and a battery capacity parameter of both ends of the secondary battery in real time during at least one process of a charging process and a discharging process; determining a characteristic point of the voltage during its changing process, comprising: calculating a ratio of a change of the voltage relative to a change of the battery capacity parameter in real time when the voltage reaches a preset range, and determining that one characteristic point occurs during the changing process of the voltage when the ratio is greater than a characteristic threshold; and determining a uniformity of the secondary battery based on a number of the characteristic points.

Abstract: The present disclosure provides a battery cabinet of a battery box and an energy storage container including the battery cabinet.

Abstract: The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts, thereof: which inhibit picornavirus, norovirus or coronavirus replication activity. The invention further relates to pharmaceutical compositions comprising a compound of Formula (I) or a pharmaceutically acceptable salt thereof, and methods of treating or preventing a virus infection in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of Formula (I) or a pharmaceutically acceptable salt thereof.

Abstract: The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: X-A-Y-L-R??(I) which inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV life cycle of the hepatitis B virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HBV infection. The invention also relates to methods of treating an HBV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.

Abstract: Provided are a fuse and a circuit system. The fuse includes: a housing, a closed chamber being provided in the housing and being filled with an arc extinguishing filler, and a first conductive terminal and a second conductive terminal which are used as a current input end and a current output end being respectively connected to the housing; a melt which is connected in series between the first conductive terminal and the second conductive terminal, at least part of the melt being disposed through the closed chamber; and an impact apparatus, which is arranged in the housing, is positioned outside the closed chamber, and is configured to act, when receiving an excitation signal, on the melt to generate an impact force to make the melt break in the closed chamber.

Abstract: An energy storage management and control system comprising an cabinet and electrical components; the internal space of the cabinet is divided into a direct current high-voltage area, a low-voltage communication and control area, and an alternating current power distribution area; and the electrical components comprise a direct current high-voltage electrical component set in the direct current high-voltage area, a low-voltage electrical component and a communication and control electrical component set in the low-voltage communication and control area, and an alternating current power distribution component set in the alternating current power distribution area.

Abstract: The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts, thereof: which inhibit coronavirus replication activity. The invention further relates to pharmaceutical compositions comprising a compound of Formula (I) or a pharmaceutically acceptable salt thereof, and methods of treating or preventing a coronavirus infection in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of Formula (I) or a pharmaceutically acceptable salt thereof.

Abstract: A battery box, battery pack and energy storage container are provided. The battery box comprises: a bottom plate and a frame, the bottom plate and the frame together form an installation cavity, the bottom plate is provided with a number of cooling flow channels, and the cooling flow channels are used for circulating cooling medium; a coolant-converging-channel, at least one end of the bottom plate is provided with the coolant-converging-channel, the coolant-converging-channel is located inside or outside the installation cavity, and the coolant-converging-channel connects to the bottom plate and is interconnected to the cooling flow channels. The battery box, battery pack and energy storage container can achieve uniform heat dissipation of the battery module, convenient for thermal management inside the battery pack and improving battery safety.

Abstract: A sewage purification treatment apparatus capable of being assembled in a prefabricated way includes a treatment table, an aeration tank, a filter tank, a water pump, a dosing assembly, a filtering assembly, a cleaning assembly and a washing assembly, the aeration tank and the filter tank are disposed at the top of the treatment table at an interval, an aeration plate is disposed at the bottom end of the inside of the aeration tank. The cleaning assembly works with the filtering assembly to automatically clean the screen in the filtering assembly to prevent impurities from blocking the screen, meanwhile, the screen can be automatically moved out of the filter tank for easy replacement, which is very convenient.

Abstract: A method for preparing an in-situ polymerized semi-solid state battery, comprising the following steps: assembling: assembling a cathode plate, a separator and an anode plate into a case to form a dummy cell; first injection: injecting a lithium battery liquid electrolyte; aging and formation; second injection: injecting a mixture of polymer monomers, a plasticizer and an initiator, wherein the polymer monomers are a combination of vinylene carbonate and tripropargyl phosphate; aging, and in-situ polymerization at 58-65° C. to form gel, thus obtaining a low impedance semi-solid state battery. The formulation of the second injection comprises a tridimensional monomer, and the liquid electrolyte can be locked in the three-dimensional structure after crosslinking.

Abstract: The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: X-A-Y-L-R??(I) which inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV life cycle of the hepatitis B virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HBV infection. The invention also relates to methods of treating an HBV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.

Abstract: An actuator includes a drive mechanism, a shift mechanism, a screw rod mechanism and a base. The drive mechanism includes a first output shaft and a second output shaft. The shift mechanism includes a gear bracket and a first transmission gear. The first transmission gear has a rotation center extending in a first direction. The screw rod mechanism includes a number of screw assemblies, and each screw assembly includes a push rod. The second output shaft is configured to be able to drive the gear bracket to move along a second direction, so that the first transmission gear is able to mate with different screw rod assemblies. The first output shaft is configured to be able to drive the first transmission gear to rotate around its own rotation center, and then drive the screw assembly to move, so as to move the push rod.

Abstract: The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts, thereof: which inhibit coronavirus replication activity. The invention further relates to pharmaceutical compositions comprising a compound of Formula (I) or a pharmaceutically acceptable salt thereof, and methods of treating or preventing a coronavirus infection in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of Formula (I) or a pharmaceutically acceptable salt thereof.

Abstract: The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: X-A-Y-L-R??(I) which inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV life cycle of the hepatitis B virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HBV infection. The invention also relates to methods of treating an HBV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.

Abstract: The present invention relates to processes for preparing a Compound (1): or a pharmaceutically acceptable salt or solvate thereof. Compound (1) is useful as in many pharmaceutical agents, especially is useful as key intermediate in the synthesis of certain SARS-CoV-2 3CLpro inhibitors.

Abstract: A battery cell, a battery, and an electric device relating to the field of battery.

Abstract: The present disclosure relates a method for reducing animal weight, comprising administering to a patient in need thereof a therapeutically or prophylactically effective amount of a mulberry extract. The mulberry extract comprises: 3% to 99% of an alkaloid, 0.2% to 70% of a polysaccharide, 0% to 50% of an amino acid, 0% to 10% of flavone, and 0% to 25% of other components. The mulberry extract of the present disclosure can be used for controlling weight gain, and has a good therapeutic effect on type 2 diabetes with obesity.

Abstract: A surface water quality monitoring method based on a high spatial resolution satellite includes: step 1. building standard surface water quality pools by mixing natural water bodies with clean water in different proportions to obtain surface water quality data; step 2. obtaining high spatial resolution remote sensing images for processing; step 3. identifying remote sensing bands with higher correlation through correlation analysis by presetting ratio values of remote sensor data bands and the standard surface water quality pools; step 4. building a water quality parameter retrieval model, and comparing and retrieving the remote sensing bands with higher correlation and the surface water quality data to obtain water quality data; and step 5. identifying abnormal points of the water quality based on the water quality data and water quality data threshold of the surface water.

Abstract: The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts, thereof: which inhibit coronavirus replication activity. The invention further relates to pharmaceutical compositions comprising a compound of Formula (I) or a pharmaceutically acceptable salt thereof, and methods of treating or preventing a coronavirus infection in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of Formula (I) or a pharmaceutically acceptable salt thereof.